...Introduction: BEXIMCO Group is the largest private sector industrial conglomerate in Bangladesh engaged in diverse business areas. BEXIMCO comprises of five publicly listed companies and sixteen private companies. The Group turnover in 2008 was BDT 18.5 billion. BEXIMCO employs 35,000 people and has 230,000 shareholders. BEXIMCO’s shares constitute 4.84% of the market capitalization of DSE. History of BEXIMCO: Since independence Bangladesh has come a long way, and the Beximco Group of Companies is honored to have had a role in the development of its parent nation. The Group has worked with a simple philosophy; identify an important need and then do everything possible to successfully satiate that need, in a manner which best facilitates the well being of the nation. As a result Beximco has focused on those industries which give Bangladesh a competitive advantage in the global market place in many cases creating the industries for the first time in the region. Throughout its four and a half decade journey the Group has been one of the leading innovators in the country. Presently Beximco Group comprises twenty one companies of which five are listed with the Dhaka Stock Exchange employing over 35,000 personnel and is the largest private sector industrial conglomerate in the nation. . In the course of its growth, it has created industrial and management capabilities that will serve the country for generations to come. It was the first local conglomerate to embrace an international...
Words: 4671 - Pages: 19
...Introduction: BEXIMCO Group is the largest private sector industrial conglomerate in Bangladesh engaged in diverse business areas. BEXIMCO comprises of five publicly listed companies and sixteen private companies. The Group turnover in 2008 was BDT 18.5 billion. BEXIMCO employs 35,000 people and has 230,000 shareholders. BEXIMCO’s shares constitute 4.84% of the market capitalization of DSE. History of BEXIMCO: Since independence Bangladesh has come a long way, and the Beximco Group of Companies is honored to have had a role in the development of its parent nation. The Group has worked with a simple philosophy; identify an important need and then do everything possible to successfully satiate that need, in a manner which best facilitates the well being of the nation. As a result Beximco has focused on those industries which give Bangladesh a competitive advantage in the global market place in many cases creating the industries for the first time in the region. Throughout its four and a half decade journey the Group has been one of the leading innovators in the country. Presently Beximco Group comprises twenty one companies of which five are listed with the Dhaka Stock Exchange employing over 35,000 personnel and is the largest private sector industrial conglomerate in the nation. . In the course of its growth, it has created industrial and management capabilities that will serve the country for generations to come. It was the first local conglomerate to embrace an international...
Words: 4631 - Pages: 19
...An assignment on BEXIMCO PHARMACEUTICALS LTD Submitted To Professor Dr. Durgadas Bhattacherjee Adjunct Professor Department of Business Administration Faculty of Business & Economics Submitted By Md. Amjad Hosen ID: 151-12-596 Semester: Summer 2015 Subject: Strategic Management Program: E.M.B.A Section: ‘B’ DAFFODIL INTERNATIONAL UNIVERSITY Date of Submission: August 09, 2015 Table of Content | Topic Pages 1. Historical Background 2. Company profile 3. Organizational Structure 4. Product Line 5. Market Scenario 6. Business level Strategy Pursued 7. Competitive Advantage 8. SWOT Analysis 9. Possible Measures to Improve Performance 10. Relationship between Business Level Strategy and Performance 11. What I Learned 12. Conclusion Historical Background Beximco Pharma is a leading edge pharmaceutical company and is a member of the Beximco Group, the largest private sector industrial conglomerate in Bangladesh. The firm started operation in 1980, manufacturing products under the licenses of Bayer AG of Germany and Upjohn Inc. of USA and now have grown to become nation's one of the leading pharmaceutical companies, supplying more than...
Words: 2662 - Pages: 11
...Introduction: ACI formulation Limited (ACI FL) is a subsidiary of ACI limited, located at Gazipur in the out skirt of Dhaka. ACI FL manufactures majority of the products of ACI Strategic Business Limited except for the Pharmaceutical Division. The factory is equipped with the state of the art facilities for product formulations and process innovation. These include modern computerized equipment like HPLC and GLC. The product range manufactured at ACI FL include Crop Protection Chemicals like Insecticides, herbicides and fungicides in granular, powder and liquid, mosquito pesticides in the forms of aerosols, vaporizers and coils house hold chemicals like toilet cleaners and hand wash. History: ACI Limited was established as the subsidiary of Imperial Chemical Industries (ICI) in the then East Pakistan in 1968. After independence, the company was incorporated in Bangladesh in 1973 as ICI Bangladesh Manufacturers limited as a Public Limited Company. In 1992, the company was divested to local management and the name of the company changed to Advanced Chemical Industries (ACI) Limited. ACI inherited the rich ICI culture of product quality, customer service and social responsibility. Initially in 1992, ACI started primarily with pharmaceutical business with a turnover of BDT 80 million only but later the new management brought about fundamental changes in the policies and in the year 2008 turnover grew to over BDT 7,365 million. The Company has diversified business interest in...
Words: 490 - Pages: 2
...Chapter A: Introduction Executive Summary SQUARE today symbolizes a name – a state of mind. But its journey to the growth and prosperity has been no bed of roses. From the inception in 1958, it has today burgeoned into one of the top line conglomerates in Bangladesh. Square Pharmaceuticals Ltd., the flagship company, is holding the strong leadership position in the pharmaceutical industry of Bangladesh since 1985 and is now on its way to becoming a high performance global player. SQUARE today is more than just an organization, it is an institute. In a career spanning across four and half decades it has pioneered the development of the local business in fields as diverse as Pharmaceuticals, Toiletries, Garments, Textile, Information Technology, Health Products, Food Products, Hospital, etc. With an average Annual turnover of over US$ 200 million and a workforce of about 3500 the SQUARE Group is a true icon of the Bangladesh business sector. Vision satement We view business as a means to the material and social wellbeing of the investors, employees and the society at large, leading to accretion of wealth through financial and moral gains as a part of the process of the human civilization. Mission statement Our Mission is to produce and provide quality & innovative healthcare relief for people, maintain stringently ethical standard in business operation also ensuring benefit to the shareholders, stakeholders and the society at large. Chapter B: ...
Words: 5298 - Pages: 22
...Shinepukur Ceramics Limited (SCL) Disclaimer: The contents of this presentation are entirely based on disclosures made by the company. Therefore, DSE does not assume any responsibility on the authenticity of the facts and figures presented thereof. (If there is any contrary information please communicate with DSE through e-mail: listing@dsebd.org) Brief Overview of the Company 1. Date of Incorporation : January 26, 1997 as a private Company , Converted into Public Ltd. Co. on 07.05.08 2. Commencement of Business : Porcelain on 01.04.1999 and Bone China on 01.11.1999 2. Authorised Capital : Tk.5000.00 mn 3. Paid up Capital : Tk. 700.24 mn 4. Nature of Business : Manufacturing and Marketing of high quality porcelain and high value added Bone China Tableware. 5. Offloading of 3,50,11,800 Ordinary shares of Tk. 10 each (Total Tk.350.12 mn Face Value). History of Paid up Capital Year 2003 2004 2005 2006 2007 30.06.08 Issued, Subscribed and Paid-up Capital (million Tk.) 660.60 660.60 660.60 660.60 660.60 700.24 (Capital in Million) Sources of Capital Sponsor Do Do Do Do Bonus Issue Manager: AB Bank (Merchant Banking Wing) Auditor: M. J. Abedin & CO. Shinepukur Ceramics Limited (SCL) At a glance Shinepukur Ceramics Limited (SCL) was incorporated in Bangladesh on 26th January 1997 under the Companies Act 1994 as a private Company. SCL launched its production of Porcelain on 1st April, 1999 and Bone China on 1st November, 1999. It was converted into a public Company...
Words: 1792 - Pages: 8
...Prepared by: Eshita Iman CHAPTER 1: INTRODUCTION 3-6 1.1 EXECUTIVE SUMMARY 3 1.2 SCOPE & OBJECTIVE OF THE STUDY 4 1.3 PURPOSE OF THE STUDY 5 1.4 METHODOLOGY OF THE STUDY 5 1.5 LIMITATION OF THE STUDY 6 CHAPTER 2:COMPANY CRFONOLOGIES 7-9 2.1COMPANY OVERVIEW 7 2.2 VISON 8 2.3 MISSION 8 2.4 KEY COMPANY INFORMATION 8-9 CHAPTER 3:HUMAN RESOURCE MANAGEMENT 10-11 3.1HUMAN REROURCE MANAGEMENT 10 3.2 HRM PROCESS 11 3.3 HRM PLAN & FORECASTING IN BPL 11 CHAPTER 4: RECRUIT & SELECTION PROCESS IN BPL 12-24 4.1 RECRUIT & SELECTION 13 4.1.1 RECRUITMENT OBJECTIVES 14 4.1 .2 RECRUITMENT PROCESS 14 4.1.3 SOURCE OF RECRUITMENT 14 1.INTERNAL SOURCE 15 2. JOB POSTING PROGRAMS 15 3.DEPARTING EMPOLYES 15 4.EXTERNAL SOURCE 15 5.ADVERTISEMENT 15 6. EMPLOY REFERRALS 15 7.EMPLOYMENT EGENCY 16 8.WALK-INS AND WRITE INS 16 9.CONSULTING THE CV BAnk 16 4.1.4 SELECTION PROCESS 16 4.2. SELECTION PROCESS 22 4.2.1 INDUCTION & PROBATION PERIOD FOR NEW EMPLOY 23 4.2.2 JOB DESCRIPTION 23-24 CHAPTER: 5 TRAINING & DEVELOPMENT PROGRAM OF BPL 24-32 5.1 TRAINING & DEVELOPMENT PROGRAM OF BPL 24 5.1.2 INDUCTION TRAINING 24 5.1.3 CLASSROOM TRAINING 24 5.1.4 OFF THE JOB TRAINING 25 5.1.5 ON-THE-JOB TRAINING 25 5.2 EMPLOYMENT DEVELOPMENT 27 5.3 TYPES OF TRAINING 27 5.3.1 TRAINING PROCESS 28 5.4 EVALUATING THE RESULT 28 5.5 TRAINING AIDS 28 5.6 PERFORMANCE APPRAISAL 28 5.7 EMPLOYEE COMPENSATION 29 5.8 MOTIVATING...
Words: 8760 - Pages: 36
...Balance Sheet for Beximco Pharmaceuticals Ltd GDR (BXP) from Morn... http://financials.morningstar.com/balance-sheet/bs.html?t=BXP®ion=gbr 1 of 3 Log In Premium Company Site Company News Welcome! Membership Home Portfolio Nasdaq 4756.22 27.55(0.58%) Stocks Bonds S&P 500 2031.54 15.61(0.77%) Funds ETFs DJIA 17396.37 144.84(0.84%) CEF Markets Gold 1266.10 36.80(2.99%) Tools Real Life Finance Discuss Light Crude 39.77 1.31(3.41%) Advertisement Beximco Pharmaceuticals Ltd GDR BXP Add to Portfolio Quote Chart Income Statement Statement Type Annual Get E-mail Alerts Stock Analysis Print This Page Performance Balance Sheet Data Type As of Reported PDF Report Key Ratios 10 Things to Start Doing Data Question Financials Valuation Insiders Ownership Filings Bonds Cash Flow Period 5 Years Show Report Dates Data Scroll View Rounding Export Ascending 3/17/2016 9:24 PM Balance Sheet for Beximco Pharmaceuticals Ltd GDR (BXP) from Morn... http://financials.morningstar.com/balance-sheet/bs.html?t=BXP®ion=gbr 2 of 3 Fiscal year ends in December 2010-12 2011-12 2012-12 2013-12 2014-12 21,372 23,033 24,590 27,471 29,001 6,192 7,149 8,197 8,903 8,366 Cash 2,331 2,712 3,240 3,622 2,697 Cash and cash equivale... 1,471 519 553 596 222 859 2,193 2,687 3,026 2,475 BDT in Million except per share data Assets Current assets Short-term investments 2,331 2,712 3,240 3,622 2,697 Receivables Total cash...
Words: 946 - Pages: 4
... 23, 2011 LETTER OF TRANSMITTAL August 23, 2011 Ms.Jafrin Sultana Assistant professor Department Of Business Administration Dhaka City College Dhaka-1205 Subject: Submission of Report on “Beximco Pharmaceutical Limited”. Dear Sir, We have been recommended to prepare a report on “Beximco Pharmaceutical Limited” that was assigned by the Department of Business Administration of Dhaka city College on June,2011.we are highly grateful for providing us such an opportunity to study & submit the report. This report helps us to know about the service sector in Bangladesh and the various problems and potentiality of this sector. Through this process we have tried to obtain a clear knowledge and accurate information about the pharmaceutical industry. We hope that it will help us to build up Business Leader in future and proper knowledge in our academic life. We are thanking you for your kind consideration & proper guidance to prepare this report. Sincerely, Group: Batch-9; Section-D Department of Business Administration Dhaka City College Dhaka. Nur Tamanna (On behalf of the group members) ACKNOWLEDGEMENT The project paper is essential for the business studies students and also for our job sector in future. And this particular report on Beximco Pharmaceutical Limited will very much helpful for us to develop our practical experience & expertise. It is an excellent opportunity for us to have knowledge about...
Words: 10833 - Pages: 44
...Executive Summary After growing at a robust twenty plus percentage in 2010 and 2011, Bangladesh Pharmaceutical Industry experienced a slower growth in 2012. The market grew by 11.9% in value terms to reach at Tk. 94 billion (IMS: Q4 2012 report). Despite a slower growth in the market, Beximco Pharma managed to achieve desired growth and successfully improve its market share. The country continued to maintain 6% plus GDP growth rate in 2012 as well. The alarming depreciation of Taka against US Dollar that continued throughout 2011 till January 2012 has finally been restrained. Thanks to higher inward remittances, lower payment for import settlements, and moderate growth in export. The local currency appreciated by around 2.5% against US Dollar in 2012. This was somewhat a relief to the predicted risk of significant reduction of gross margin that started brewing in 2011 in the wake of deteriorating value of local currency against US Dollar, high rate of domestic inflation and increase in the interest rates. The liquidity shortage that prevailed throughout 2011 also eased up to some extent in 2012. However, the political crisis that started by end of 2012 centering the upcoming election poses some degree of uncertainty in the overall economic environment of the country and is seen as an impediment to the growth of business. The first quarter of 2013 has already been affected for such instability in the political environment and continues to remain as a risk factor. ...
Words: 5929 - Pages: 24
...COMPANY PROFILE Of Beximco Group Introduction: BEXIMCO Group is the largest private sector industrial conglomerate in Bangladesh engaged in diverse business areas. BEXIMCO comprises of five publicly listed companies and sixteen private companies. The Group turnover in 2008 was BDT 18.5 billion. BEXIMCO employs 35,000 people and has 230,000 shareholders. BEXIMCOs shares constitute 4.84% of the market capitalization of DSE History of BEXIMCO: Since independence Bangladesh has come a long way, and the Beximco Group of Companies is honored to have had a role in the development of its parent nation. The Group has worked with a simple philosophy; identify an important need and then do everything possible to successfully satiate that need, in a manner which best facilitates the well being of the nation. As a result Beximco has focused on those industries which give Bangladesh a competitive advantage in the global market place in many cases creating the industries for the first time in the region. Throughout its four and a half decade journey the Group has been one of the leading innovators in the country. Presently Beximco Group comprises twenty one companies of which five are listed with the Dhaka Stock Exchange employing over 35,000 personnel and is the largest private sector industrial conglomerate in the nation. . In the course of its growth, it has created industrial and management capabilities that will serve...
Words: 2430 - Pages: 10
...1. Historical background Beximco Pharmaceuticals Limited (BPL) is a part of Beximco Group, the largest private sector industrial conglomerate in Bangladesh. BPL develops, manufactures and markets both finished dosage form branded generic pharmaceutical products and active pharmaceutical ingredients (APIs), with products including solid dose forms, Metered Dose Inhalers, Nasal Sprays, Large Volume Intravenous Fluids, Suppositories, and Creams/Ointments. BPL produces and markets 'branded generics' for most diseases ranging from AIDS to cancer, from infection to asthma, from hypertension to diabetes, for both national and international markets. The company also manufactures active pharmaceutical ingredients and intravenous fluids and contract manufacture for major international brands of leading multinational companies. BPL utilizes state of the art manufacturing facilities. BPL also has outstanding reverse engineering capabilities. Incorporated in 1976, BPL started off as a distributor of pharmaceutical products. It imported products from global MNCs such as Bayer AG of Germany and Upjohn Inc. of USA and sold them in the local market. It eventually graduated to a manufacturer and distributor of these products in local market under licensing agreements. During the early 80s, BPL launched its own products in the local market. Beximco started its exports operation in the early 90s with APIs. Today BPL is one of the largest exporters of medicines from Bangladesh. BPL employs more...
Words: 1988 - Pages: 8
...Ratio Analysis of Financial Statements | 14 | | | | | | | | | | | | | | | | | | | | | | | | | | | Working Capital Working capital is the excess of current assets over the current liabilities. It is calculated by deducting current liabilities from current assets. Working capital = Current assets - Current liabilities 2005 | 2006 | Current assets | Current liabilities | Current assets | Current liabilities | 672,355,277 | 384,140,329 | 979,254,859 | 658,881,691 | Working capital =288,214,948 | Working capital = 320,373,168 | Current ratio The current ratio is a widely used measure for evaluating company’s liquidities & short-term debt- paying ability: Current ratio = Current assets Current liabilities 2005 | 2006 | Current assets | Current liabilities | Current assets | Current liabilities | 672,355,277 | 384,140,329 | 979,254,859 | 658,881,691 | Current ratio =1.75 | Current ratio = 1.49 | Comment The ideal current ratio of an organization is 1.2 times. The current ratio of Renata Ltd. in 2005 is 1.75 times and in 2006 is 1.49 times, which is lower than the previous year 2005. So liquidity and short-term debt paying ability is worse than the previous year. But the Renata Ltd. has liquidity ability 1.49 to pay the short term debt for 1 which is higher from the probable ideal ratio. ...
Words: 2362 - Pages: 10
...Ratio Analysis & Time Series Analysis Of 2.1 Ratio and time series analysis of Beximco Pharmaceutical 1. Inventory turnover: A ratio showing how many times a company's inventory is sold and replaced over a period. Formula: Inventory Turnover =Cost of goods sold/Average Inventory. The ratio and time series analysis of Inventory Turnover of Beximco Pharmaceutical from 2008-2012 is given below- | Inventory Turnover | 2008 | 1.346 | 2009 | 3.01 | 2010 | 3.50 | 2011 | 1.92 | 2012 | 2.07 | Interpretation: The companies ratio increases from 2008 to 2010, then decreases in 2011 and then again increases from 2012. 2. TIE ratio: Time interest earned ratio (TIE) also known as Interest coverage ratio, indicates how well a company can cover its interest payment on a pretext basis. The larger the time interest earned, the more capable the company is paying the interest on its debt. Formula: Earnings before interest and tax / Total interest ] The ratio and time series analysis of TIE Ratio from 2008-2012 given below- | Time Interest Earned | 2008 | 4.90 | 2009 | 4.03 | 2010 | 3.21 | 2011 | 3.50 | 2012 | 3.42 | Interpretation: The Ratio Increases from 2008 to 2012 to its highest level of 4.90 and then decreases in 2009 & 2010.Again ratio increase 2011. The ratio fluctuation is very high. 3. Gross Profit Margin: A financial metric used to assess a firm's financial health by revealing the proportion of...
Words: 1867 - Pages: 8
...Executive summery The paper represents the process of the planning and organizing of Beximco Pharmaceuticals, Beximco Pharmaceuticals Limited (BPL/ the Company) was incorporated as a public limited company in Bangladesh in 1976. It commenced its manufacturing operation in 1980. The company was listed with Dhaka Stock Exchange in 1985 and with Chittagong Stock Exchange on its debut in 1995. Beximco Pharmaceutical Ltd is the manufacturer and marketer of pharmaceutical product under chemical divisions of Beximco Group. Beximco Pharmaceuticals is one of the leading pharmaceutical companies in Bangladesh. It also is one of the biggest suppliers of pharmaceutical product of any Bangladeshi based company. BPL is the first Bangladeshi company to supply pharmaceutical product to Riffles Hospital the most prestigious hospital of Singapore In 2005, BPL took over Beximco Infusions Ltd., a listed company of the Beximco Group engaged in manufacturing and marketing of intravenous fluids and got enlisted with the Alternative Investment Market (AIM) of the London Stock Exchange through issuance of Global Depository Receipts (GDRs). Shares of the Company are traded in Dhaka and Chittagong Stock Exchanges of Bangladesh and its GDRs in AIM of the London Stock Exchange. The paper seeks information on the planning and organizing system that used at BPL. Different methods have been employed to analyze the data both from primary and secondary sources. It gives an idea of how information on purchases...
Words: 3604 - Pages: 15
